One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine
- PMID: 6740092
- DOI: 10.1093/clinids/6.supplement_2.s444
One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine
Abstract
Recent advances in production and standardization of noninfectious poliovirus vaccine now make it feasible to induce durable immunity against paralytic poliomyelitis with one dose of a suitably standardized vaccine. A single dose of a vaccine containing 40, 8, and 32 D-antigen units of type 1, 2, and 3, respectively, administered to six-month-old infants, was observed to induce antibody levels of greater than or equal to 1:4 in greater than 90% and immunologic memory in all. Since protection against paralysis is associated with the presence of either type-specific serum antibody or type-specific immunologic memory, and since immunologic memory once induced is irreversible, then lifelong immunity to paralytic poliomyelitis can be induced with a single dose of a suitably standardized vaccine administered at five to seven months of age. In areas of the world where exposure to poliovirus can occur before this age, vaccine should be administered earlier. Until the influence of age and/or maternal antibody has been further studied, infants immunized before the age of six months should receive a second dose after six months of age.
Similar articles
-
Vaccinology of poliomyelitis.Vaccine. 1984 Mar;2(1):59-74. doi: 10.1016/s0264-410x(98)90035-4. Vaccine. 1984. PMID: 6099644 Review.
-
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.Lancet. 1993 Jun 19;341(8860):1545-50. doi: 10.1016/0140-6736(93)90693-b. Lancet. 1993. PMID: 8099637 Clinical Trial.
-
Induction of long-term immunity to paralytic poliomyelitis by use of non-infectious vaccine.Lancet. 1984 Dec 8;2(8415):1317-21. doi: 10.1016/s0140-6736(84)90830-4. Lancet. 1984. PMID: 6150331
-
Feasible improvements in vaccines in the Expanded Programme on Immunization.Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S530-7. doi: 10.1093/clinids/11.supplement_3.s530. Rev Infect Dis. 1989. PMID: 2669097 Review.
-
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.Lancet Infect Dis. 2015 Nov;15(11):1273-82. doi: 10.1016/S1473-3099(15)00219-4. Epub 2015 Aug 26. Lancet Infect Dis. 2015. PMID: 26318714 Clinical Trial.
Cited by
-
How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin.Nat Commun. 2018 Apr 11;9(1):1386. doi: 10.1038/s41467-018-03665-3. Nat Commun. 2018. PMID: 29643370 Free PMC article.
-
Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis.J Infect Dis. 2014 Nov 1;210 Suppl 1(Suppl 1):S439-46. doi: 10.1093/infdis/jit601. Epub 2014 Mar 14. J Infect Dis. 2014. PMID: 24634499 Free PMC article. Review.
-
The final stages of the global eradication of poliomyelitis.Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120140. doi: 10.1098/rstb.2012.0140. Print 2013 Aug 5. Philos Trans R Soc Lond B Biol Sci. 2013. PMID: 23798688 Free PMC article. Review.
-
The poliomyelitis story: a scientific hegira.Yale J Biol Med. 1985 Mar-Apr;58(2):79-90. Yale J Biol Med. 1985. PMID: 2994307 Free PMC article.
-
Immunologic memory induced at birth by immunization with inactivated polio vaccine in a reduced schedule.Eur J Epidemiol. 1989 Jun;5(2):143-5. doi: 10.1007/BF00156819. Eur J Epidemiol. 1989. PMID: 2767220
MeSH terms
Substances
LinkOut - more resources
Medical